nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—BCHE—Irinotecan—lung cancer	0.165	0.551	CbGbCtD
Ramipril—BCHE—Cisplatin—lung cancer	0.134	0.449	CbGbCtD
Ramipril—BCHE—diaphragm—lung cancer	0.0297	0.221	CbGeAlD
Ramipril—ACE—pulmonary artery—lung cancer	0.0273	0.203	CbGeAlD
Ramipril—ACE—umbilical vein—lung cancer	0.018	0.134	CbGeAlD
Ramipril—SLC15A2—mammary gland—lung cancer	0.00601	0.0446	CbGeAlD
Ramipril—SLC15A1—epithelium—lung cancer	0.00536	0.0397	CbGeAlD
Ramipril—ACE—respiratory system—lung cancer	0.0046	0.0341	CbGeAlD
Ramipril—SLC15A2—respiratory system—lung cancer	0.00401	0.0297	CbGeAlD
Ramipril—ACE—epithelium—lung cancer	0.00384	0.0285	CbGeAlD
Ramipril—BCHE—respiratory system—lung cancer	0.00339	0.0252	CbGeAlD
Ramipril—SLC15A2—bronchus—lung cancer	0.0033	0.0245	CbGeAlD
Ramipril—ACE—cardiac atrium—lung cancer	0.00319	0.0237	CbGeAlD
Ramipril—SLC15A2—trachea—lung cancer	0.00296	0.022	CbGeAlD
Ramipril—BCHE—bronchus—lung cancer	0.00279	0.0207	CbGeAlD
Ramipril—ACE—bone marrow—lung cancer	0.00269	0.02	CbGeAlD
Ramipril—BCHE—trachea—lung cancer	0.00251	0.0186	CbGeAlD
Ramipril—ACE—lung—lung cancer	0.00244	0.0181	CbGeAlD
Ramipril—BCHE—cardiac atrium—lung cancer	0.00236	0.0175	CbGeAlD
Ramipril—SLC15A2—lung—lung cancer	0.00213	0.0158	CbGeAlD
Ramipril—BCHE—bone marrow—lung cancer	0.00199	0.0148	CbGeAlD
Ramipril—BCHE—lung—lung cancer	0.0018	0.0134	CbGeAlD
Ramipril—ACE—lymph node—lung cancer	0.00167	0.0124	CbGeAlD
Ramipril—SLC15A2—lymph node—lung cancer	0.00146	0.0108	CbGeAlD
Ramipril—BCHE—lymph node—lung cancer	0.00123	0.00914	CbGeAlD
Ramipril—Perindopril—ABCB1—lung cancer	0.000511	0.258	CrCbGaD
Ramipril—Lisinopril—ABCB1—lung cancer	0.00045	0.228	CrCbGaD
Ramipril—Cilazapril—ABCB1—lung cancer	0.00045	0.228	CrCbGaD
Ramipril—Enalapril—ABCB1—lung cancer	0.00033	0.167	CrCbGaD
Ramipril—Nateglinide—ALB—lung cancer	0.000236	0.12	CrCbGaD
Ramipril—Paraesthesia—Paclitaxel—lung cancer	0.000219	0.000389	CcSEcCtD
Ramipril—Bronchitis—Doxorubicin—lung cancer	0.000218	0.000387	CcSEcCtD
Ramipril—Agranulocytosis—Methotrexate—lung cancer	0.000218	0.000387	CcSEcCtD
Ramipril—Dyspnoea—Paclitaxel—lung cancer	0.000218	0.000386	CcSEcCtD
Ramipril—Somnolence—Paclitaxel—lung cancer	0.000217	0.000385	CcSEcCtD
Ramipril—Decreased appetite—Etoposide—lung cancer	0.000216	0.000384	CcSEcCtD
Ramipril—Chest pain—Docetaxel—lung cancer	0.000216	0.000383	CcSEcCtD
Ramipril—Myalgia—Docetaxel—lung cancer	0.000216	0.000383	CcSEcCtD
Ramipril—Arthralgia—Docetaxel—lung cancer	0.000216	0.000383	CcSEcCtD
Ramipril—Pancytopenia—Doxorubicin—lung cancer	0.000216	0.000383	CcSEcCtD
Ramipril—Nausea—Vinorelbine—lung cancer	0.000216	0.000382	CcSEcCtD
Ramipril—Gastrointestinal disorder—Etoposide—lung cancer	0.000215	0.000381	CcSEcCtD
Ramipril—Dyspepsia—Paclitaxel—lung cancer	0.000215	0.000381	CcSEcCtD
Ramipril—Body temperature increased—Cisplatin—lung cancer	0.000215	0.000381	CcSEcCtD
Ramipril—Asthenia—Irinotecan—lung cancer	0.000215	0.000381	CcSEcCtD
Ramipril—Fatigue—Etoposide—lung cancer	0.000215	0.000381	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000214	0.00038	CcSEcCtD
Ramipril—Constipation—Etoposide—lung cancer	0.000213	0.000378	CcSEcCtD
Ramipril—Neutropenia—Doxorubicin—lung cancer	0.000212	0.000377	CcSEcCtD
Ramipril—Decreased appetite—Paclitaxel—lung cancer	0.000212	0.000376	CcSEcCtD
Ramipril—Dry mouth—Docetaxel—lung cancer	0.000211	0.000374	CcSEcCtD
Ramipril—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000211	0.000374	CcSEcCtD
Ramipril—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000211	0.000374	CcSEcCtD
Ramipril—Fatigue—Paclitaxel—lung cancer	0.000211	0.000373	CcSEcCtD
Ramipril—Hepatitis—Methotrexate—lung cancer	0.00021	0.000372	CcSEcCtD
Ramipril—Asthenia—Gemcitabine—lung cancer	0.000209	0.000371	CcSEcCtD
Ramipril—Constipation—Paclitaxel—lung cancer	0.000209	0.00037	CcSEcCtD
Ramipril—Confusional state—Docetaxel—lung cancer	0.000209	0.00037	CcSEcCtD
Ramipril—Photosensitivity reaction—Doxorubicin—lung cancer	0.000207	0.000368	CcSEcCtD
Ramipril—Anaphylactic shock—Docetaxel—lung cancer	0.000207	0.000367	CcSEcCtD
Ramipril—Oedema—Docetaxel—lung cancer	0.000207	0.000367	CcSEcCtD
Ramipril—Weight increased—Doxorubicin—lung cancer	0.000207	0.000367	CcSEcCtD
Ramipril—Pruritus—Gemcitabine—lung cancer	0.000206	0.000366	CcSEcCtD
Ramipril—Feeling abnormal—Etoposide—lung cancer	0.000205	0.000364	CcSEcCtD
Ramipril—Diarrhoea—Irinotecan—lung cancer	0.000205	0.000363	CcSEcCtD
Ramipril—Gastrointestinal pain—Etoposide—lung cancer	0.000204	0.000361	CcSEcCtD
Ramipril—Shock—Docetaxel—lung cancer	0.000204	0.000361	CcSEcCtD
Ramipril—Nervous system disorder—Docetaxel—lung cancer	0.000203	0.00036	CcSEcCtD
Ramipril—Thrombocytopenia—Docetaxel—lung cancer	0.000203	0.000359	CcSEcCtD
Ramipril—Visual impairment—Methotrexate—lung cancer	0.000202	0.000359	CcSEcCtD
Ramipril—Tachycardia—Docetaxel—lung cancer	0.000202	0.000358	CcSEcCtD
Ramipril—Feeling abnormal—Paclitaxel—lung cancer	0.000201	0.000357	CcSEcCtD
Ramipril—Skin disorder—Docetaxel—lung cancer	0.000201	0.000357	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000201	0.000356	CcSEcCtD
Ramipril—Hypersensitivity—Cisplatin—lung cancer	0.0002	0.000355	CcSEcCtD
Ramipril—Gastrointestinal pain—Paclitaxel—lung cancer	0.0002	0.000354	CcSEcCtD
Ramipril—Diarrhoea—Gemcitabine—lung cancer	0.0002	0.000354	CcSEcCtD
Ramipril—Renal failure—Doxorubicin—lung cancer	0.000199	0.000353	CcSEcCtD
Ramipril—Erythema multiforme—Methotrexate—lung cancer	0.000199	0.000352	CcSEcCtD
Ramipril—Neuropathy peripheral—Doxorubicin—lung cancer	0.000199	0.000352	CcSEcCtD
Ramipril—Dizziness—Irinotecan—lung cancer	0.000198	0.000351	CcSEcCtD
Ramipril—Urticaria—Etoposide—lung cancer	0.000198	0.000351	CcSEcCtD
Ramipril—Stomatitis—Doxorubicin—lung cancer	0.000197	0.00035	CcSEcCtD
Ramipril—Jaundice—Doxorubicin—lung cancer	0.000197	0.00035	CcSEcCtD
Ramipril—Anorexia—Docetaxel—lung cancer	0.000197	0.00035	CcSEcCtD
Ramipril—Abdominal pain—Etoposide—lung cancer	0.000197	0.000349	CcSEcCtD
Ramipril—Body temperature increased—Etoposide—lung cancer	0.000197	0.000349	CcSEcCtD
Ramipril—Conjunctivitis—Doxorubicin—lung cancer	0.000197	0.000349	CcSEcCtD
Ramipril—Urinary tract infection—Doxorubicin—lung cancer	0.000197	0.000349	CcSEcCtD
Ramipril—Tinnitus—Methotrexate—lung cancer	0.000196	0.000347	CcSEcCtD
Ramipril—Asthenia—Cisplatin—lung cancer	0.000195	0.000346	CcSEcCtD
Ramipril—Sweating—Doxorubicin—lung cancer	0.000194	0.000344	CcSEcCtD
Ramipril—Urticaria—Paclitaxel—lung cancer	0.000194	0.000344	CcSEcCtD
Ramipril—Hypotension—Docetaxel—lung cancer	0.000193	0.000343	CcSEcCtD
Ramipril—Abdominal pain—Paclitaxel—lung cancer	0.000193	0.000342	CcSEcCtD
Ramipril—Body temperature increased—Paclitaxel—lung cancer	0.000193	0.000342	CcSEcCtD
Ramipril—Hepatobiliary disease—Doxorubicin—lung cancer	0.000192	0.00034	CcSEcCtD
Ramipril—Epistaxis—Doxorubicin—lung cancer	0.000191	0.000339	CcSEcCtD
Ramipril—Vomiting—Irinotecan—lung cancer	0.00019	0.000338	CcSEcCtD
Ramipril—Sinusitis—Doxorubicin—lung cancer	0.00019	0.000337	CcSEcCtD
Ramipril—Immune system disorder—Methotrexate—lung cancer	0.00019	0.000336	CcSEcCtD
Ramipril—Mediastinal disorder—Methotrexate—lung cancer	0.000189	0.000336	CcSEcCtD
Ramipril—Agranulocytosis—Doxorubicin—lung cancer	0.000189	0.000335	CcSEcCtD
Ramipril—Rash—Irinotecan—lung cancer	0.000189	0.000335	CcSEcCtD
Ramipril—Dermatitis—Irinotecan—lung cancer	0.000189	0.000334	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000189	0.000334	CcSEcCtD
Ramipril—Headache—Irinotecan—lung cancer	0.000188	0.000333	CcSEcCtD
Ramipril—Insomnia—Docetaxel—lung cancer	0.000187	0.000332	CcSEcCtD
Ramipril—Diarrhoea—Cisplatin—lung cancer	0.000186	0.00033	CcSEcCtD
Ramipril—Paraesthesia—Docetaxel—lung cancer	0.000186	0.00033	CcSEcCtD
Ramipril—Alopecia—Methotrexate—lung cancer	0.000186	0.000329	CcSEcCtD
Ramipril—Vomiting—Gemcitabine—lung cancer	0.000185	0.000329	CcSEcCtD
Ramipril—Dyspnoea—Docetaxel—lung cancer	0.000185	0.000327	CcSEcCtD
Ramipril—Somnolence—Docetaxel—lung cancer	0.000184	0.000326	CcSEcCtD
Ramipril—Mental disorder—Methotrexate—lung cancer	0.000184	0.000326	CcSEcCtD
Ramipril—Rash—Gemcitabine—lung cancer	0.000184	0.000326	CcSEcCtD
Ramipril—Dermatitis—Gemcitabine—lung cancer	0.000184	0.000326	CcSEcCtD
Ramipril—Hypersensitivity—Etoposide—lung cancer	0.000183	0.000325	CcSEcCtD
Ramipril—Erythema—Methotrexate—lung cancer	0.000183	0.000324	CcSEcCtD
Ramipril—Malnutrition—Methotrexate—lung cancer	0.000183	0.000324	CcSEcCtD
Ramipril—Headache—Gemcitabine—lung cancer	0.000183	0.000324	CcSEcCtD
Ramipril—Dyspepsia—Docetaxel—lung cancer	0.000182	0.000323	CcSEcCtD
Ramipril—Hepatitis—Doxorubicin—lung cancer	0.000182	0.000322	CcSEcCtD
Ramipril—Decreased appetite—Docetaxel—lung cancer	0.00018	0.000319	CcSEcCtD
Ramipril—Hypersensitivity—Paclitaxel—lung cancer	0.00018	0.000319	CcSEcCtD
Ramipril—Oedema peripheral—Doxorubicin—lung cancer	0.000179	0.000318	CcSEcCtD
Ramipril—Dysgeusia—Methotrexate—lung cancer	0.000179	0.000317	CcSEcCtD
Ramipril—Gastrointestinal disorder—Docetaxel—lung cancer	0.000179	0.000317	CcSEcCtD
Ramipril—Asthenia—Etoposide—lung cancer	0.000179	0.000317	CcSEcCtD
Ramipril—Connective tissue disorder—Doxorubicin—lung cancer	0.000179	0.000317	CcSEcCtD
Ramipril—Fatigue—Docetaxel—lung cancer	0.000178	0.000316	CcSEcCtD
Ramipril—Nausea—Irinotecan—lung cancer	0.000178	0.000315	CcSEcCtD
Ramipril—Constipation—Docetaxel—lung cancer	0.000177	0.000314	CcSEcCtD
Ramipril—Pruritus—Etoposide—lung cancer	0.000176	0.000312	CcSEcCtD
Ramipril—Visual impairment—Doxorubicin—lung cancer	0.000175	0.000311	CcSEcCtD
Ramipril—Asthenia—Paclitaxel—lung cancer	0.000175	0.000311	CcSEcCtD
Ramipril—Nausea—Gemcitabine—lung cancer	0.000173	0.000307	CcSEcCtD
Ramipril—Vomiting—Cisplatin—lung cancer	0.000173	0.000307	CcSEcCtD
Ramipril—Pruritus—Paclitaxel—lung cancer	0.000173	0.000306	CcSEcCtD
Ramipril—Erythema multiforme—Doxorubicin—lung cancer	0.000172	0.000305	CcSEcCtD
Ramipril—Rash—Cisplatin—lung cancer	0.000171	0.000304	CcSEcCtD
Ramipril—Dermatitis—Cisplatin—lung cancer	0.000171	0.000304	CcSEcCtD
Ramipril—Feeling abnormal—Docetaxel—lung cancer	0.000171	0.000302	CcSEcCtD
Ramipril—Diarrhoea—Etoposide—lung cancer	0.00017	0.000302	CcSEcCtD
Ramipril—Ill-defined disorder—Methotrexate—lung cancer	0.00017	0.000301	CcSEcCtD
Ramipril—Tinnitus—Doxorubicin—lung cancer	0.00017	0.000301	CcSEcCtD
Ramipril—Gastrointestinal pain—Docetaxel—lung cancer	0.000169	0.0003	CcSEcCtD
Ramipril—Flushing—Doxorubicin—lung cancer	0.000169	0.000299	CcSEcCtD
Ramipril—Diarrhoea—Paclitaxel—lung cancer	0.000167	0.000296	CcSEcCtD
Ramipril—Malaise—Methotrexate—lung cancer	0.000165	0.000292	CcSEcCtD
Ramipril—Dizziness—Etoposide—lung cancer	0.000165	0.000292	CcSEcCtD
Ramipril—Immune system disorder—Doxorubicin—lung cancer	0.000164	0.000291	CcSEcCtD
Ramipril—Vertigo—Methotrexate—lung cancer	0.000164	0.000291	CcSEcCtD
Ramipril—Mediastinal disorder—Doxorubicin—lung cancer	0.000164	0.000291	CcSEcCtD
Ramipril—Abdominal pain—Docetaxel—lung cancer	0.000164	0.00029	CcSEcCtD
Ramipril—Body temperature increased—Docetaxel—lung cancer	0.000164	0.00029	CcSEcCtD
Ramipril—Leukopenia—Methotrexate—lung cancer	0.000164	0.00029	CcSEcCtD
Ramipril—Arrhythmia—Doxorubicin—lung cancer	0.000162	0.000288	CcSEcCtD
Ramipril—Dizziness—Paclitaxel—lung cancer	0.000161	0.000286	CcSEcCtD
Ramipril—Nausea—Cisplatin—lung cancer	0.000161	0.000286	CcSEcCtD
Ramipril—Alopecia—Doxorubicin—lung cancer	0.000161	0.000285	CcSEcCtD
Ramipril—Cough—Methotrexate—lung cancer	0.00016	0.000283	CcSEcCtD
Ramipril—Mental disorder—Doxorubicin—lung cancer	0.000159	0.000282	CcSEcCtD
Ramipril—Convulsion—Methotrexate—lung cancer	0.000158	0.000281	CcSEcCtD
Ramipril—Vomiting—Etoposide—lung cancer	0.000158	0.000281	CcSEcCtD
Ramipril—Malnutrition—Doxorubicin—lung cancer	0.000158	0.000281	CcSEcCtD
Ramipril—Erythema—Doxorubicin—lung cancer	0.000158	0.000281	CcSEcCtD
Ramipril—Rash—Etoposide—lung cancer	0.000157	0.000278	CcSEcCtD
Ramipril—Dermatitis—Etoposide—lung cancer	0.000157	0.000278	CcSEcCtD
Ramipril—Headache—Etoposide—lung cancer	0.000156	0.000277	CcSEcCtD
Ramipril—Arthralgia—Methotrexate—lung cancer	0.000156	0.000276	CcSEcCtD
Ramipril—Myalgia—Methotrexate—lung cancer	0.000156	0.000276	CcSEcCtD
Ramipril—Chest pain—Methotrexate—lung cancer	0.000156	0.000276	CcSEcCtD
Ramipril—Tension—Doxorubicin—lung cancer	0.000155	0.000275	CcSEcCtD
Ramipril—Vomiting—Paclitaxel—lung cancer	0.000155	0.000275	CcSEcCtD
Ramipril—Dysgeusia—Doxorubicin—lung cancer	0.000155	0.000275	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000155	0.000274	CcSEcCtD
Ramipril—Rash—Paclitaxel—lung cancer	0.000154	0.000273	CcSEcCtD
Ramipril—Dermatitis—Paclitaxel—lung cancer	0.000154	0.000273	CcSEcCtD
Ramipril—Discomfort—Methotrexate—lung cancer	0.000154	0.000273	CcSEcCtD
Ramipril—Nervousness—Doxorubicin—lung cancer	0.000154	0.000273	CcSEcCtD
Ramipril—Headache—Paclitaxel—lung cancer	0.000153	0.000271	CcSEcCtD
Ramipril—Hypersensitivity—Docetaxel—lung cancer	0.000152	0.00027	CcSEcCtD
Ramipril—Muscle spasms—Doxorubicin—lung cancer	0.000152	0.00027	CcSEcCtD
Ramipril—Confusional state—Methotrexate—lung cancer	0.00015	0.000267	CcSEcCtD
Ramipril—Anaphylactic shock—Methotrexate—lung cancer	0.000149	0.000265	CcSEcCtD
Ramipril—Asthenia—Docetaxel—lung cancer	0.000149	0.000263	CcSEcCtD
Ramipril—Nausea—Etoposide—lung cancer	0.000148	0.000262	CcSEcCtD
Ramipril—Ill-defined disorder—Doxorubicin—lung cancer	0.000147	0.00026	CcSEcCtD
Ramipril—Pruritus—Docetaxel—lung cancer	0.000146	0.00026	CcSEcCtD
Ramipril—Nervous system disorder—Methotrexate—lung cancer	0.000146	0.000259	CcSEcCtD
Ramipril—Thrombocytopenia—Methotrexate—lung cancer	0.000146	0.000259	CcSEcCtD
Ramipril—Agitation—Doxorubicin—lung cancer	0.000145	0.000258	CcSEcCtD
Ramipril—Nausea—Paclitaxel—lung cancer	0.000145	0.000257	CcSEcCtD
Ramipril—Skin disorder—Methotrexate—lung cancer	0.000145	0.000257	CcSEcCtD
Ramipril—Hyperhidrosis—Methotrexate—lung cancer	0.000144	0.000256	CcSEcCtD
Ramipril—Malaise—Doxorubicin—lung cancer	0.000143	0.000253	CcSEcCtD
Ramipril—Vertigo—Doxorubicin—lung cancer	0.000142	0.000252	CcSEcCtD
Ramipril—Anorexia—Methotrexate—lung cancer	0.000142	0.000252	CcSEcCtD
Ramipril—Syncope—Doxorubicin—lung cancer	0.000142	0.000252	CcSEcCtD
Ramipril—Leukopenia—Doxorubicin—lung cancer	0.000142	0.000251	CcSEcCtD
Ramipril—Diarrhoea—Docetaxel—lung cancer	0.000142	0.000251	CcSEcCtD
Ramipril—Palpitations—Doxorubicin—lung cancer	0.00014	0.000248	CcSEcCtD
Ramipril—Hypotension—Methotrexate—lung cancer	0.000139	0.000247	CcSEcCtD
Ramipril—Loss of consciousness—Doxorubicin—lung cancer	0.000139	0.000247	CcSEcCtD
Ramipril—Cough—Doxorubicin—lung cancer	0.000138	0.000245	CcSEcCtD
Ramipril—Convulsion—Doxorubicin—lung cancer	0.000137	0.000243	CcSEcCtD
Ramipril—Dizziness—Docetaxel—lung cancer	0.000137	0.000243	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000136	0.000241	CcSEcCtD
Ramipril—Insomnia—Methotrexate—lung cancer	0.000135	0.000239	CcSEcCtD
Ramipril—Myalgia—Doxorubicin—lung cancer	0.000135	0.000239	CcSEcCtD
Ramipril—Chest pain—Doxorubicin—lung cancer	0.000135	0.000239	CcSEcCtD
Ramipril—Arthralgia—Doxorubicin—lung cancer	0.000135	0.000239	CcSEcCtD
Ramipril—Anxiety—Doxorubicin—lung cancer	0.000134	0.000238	CcSEcCtD
Ramipril—Paraesthesia—Methotrexate—lung cancer	0.000134	0.000238	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000134	0.000237	CcSEcCtD
Ramipril—Discomfort—Doxorubicin—lung cancer	0.000133	0.000236	CcSEcCtD
Ramipril—Dyspnoea—Methotrexate—lung cancer	0.000133	0.000236	CcSEcCtD
Ramipril—Somnolence—Methotrexate—lung cancer	0.000133	0.000235	CcSEcCtD
Ramipril—Dry mouth—Doxorubicin—lung cancer	0.000132	0.000234	CcSEcCtD
Ramipril—Vomiting—Docetaxel—lung cancer	0.000132	0.000233	CcSEcCtD
Ramipril—Dyspepsia—Methotrexate—lung cancer	0.000131	0.000233	CcSEcCtD
Ramipril—Rash—Docetaxel—lung cancer	0.000131	0.000231	CcSEcCtD
Ramipril—Dermatitis—Docetaxel—lung cancer	0.00013	0.000231	CcSEcCtD
Ramipril—Confusional state—Doxorubicin—lung cancer	0.00013	0.000231	CcSEcCtD
Ramipril—Decreased appetite—Methotrexate—lung cancer	0.00013	0.00023	CcSEcCtD
Ramipril—Headache—Docetaxel—lung cancer	0.00013	0.00023	CcSEcCtD
Ramipril—Anaphylactic shock—Doxorubicin—lung cancer	0.000129	0.000229	CcSEcCtD
Ramipril—Oedema—Doxorubicin—lung cancer	0.000129	0.000229	CcSEcCtD
Ramipril—Gastrointestinal disorder—Methotrexate—lung cancer	0.000129	0.000228	CcSEcCtD
Ramipril—Fatigue—Methotrexate—lung cancer	0.000129	0.000228	CcSEcCtD
Ramipril—Shock—Doxorubicin—lung cancer	0.000127	0.000225	CcSEcCtD
Ramipril—Nervous system disorder—Doxorubicin—lung cancer	0.000127	0.000225	CcSEcCtD
Ramipril—Thrombocytopenia—Doxorubicin—lung cancer	0.000126	0.000224	CcSEcCtD
Ramipril—Tachycardia—Doxorubicin—lung cancer	0.000126	0.000224	CcSEcCtD
Ramipril—Skin disorder—Doxorubicin—lung cancer	0.000125	0.000222	CcSEcCtD
Ramipril—Hyperhidrosis—Doxorubicin—lung cancer	0.000125	0.000221	CcSEcCtD
Ramipril—Anorexia—Doxorubicin—lung cancer	0.000123	0.000218	CcSEcCtD
Ramipril—Nausea—Docetaxel—lung cancer	0.000123	0.000218	CcSEcCtD
Ramipril—Feeling abnormal—Methotrexate—lung cancer	0.000123	0.000218	CcSEcCtD
Ramipril—Gastrointestinal pain—Methotrexate—lung cancer	0.000122	0.000216	CcSEcCtD
Ramipril—Hypotension—Doxorubicin—lung cancer	0.000121	0.000214	CcSEcCtD
Ramipril—Urticaria—Methotrexate—lung cancer	0.000119	0.00021	CcSEcCtD
Ramipril—Abdominal pain—Methotrexate—lung cancer	0.000118	0.000209	CcSEcCtD
Ramipril—Body temperature increased—Methotrexate—lung cancer	0.000118	0.000209	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000118	0.000209	CcSEcCtD
Ramipril—Insomnia—Doxorubicin—lung cancer	0.000117	0.000207	CcSEcCtD
Ramipril—Paraesthesia—Doxorubicin—lung cancer	0.000116	0.000206	CcSEcCtD
Ramipril—Dyspnoea—Doxorubicin—lung cancer	0.000115	0.000204	CcSEcCtD
Ramipril—Somnolence—Doxorubicin—lung cancer	0.000115	0.000204	CcSEcCtD
Ramipril—Dyspepsia—Doxorubicin—lung cancer	0.000114	0.000202	CcSEcCtD
Ramipril—Decreased appetite—Doxorubicin—lung cancer	0.000112	0.000199	CcSEcCtD
Ramipril—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000112	0.000198	CcSEcCtD
Ramipril—Fatigue—Doxorubicin—lung cancer	0.000111	0.000197	CcSEcCtD
Ramipril—Constipation—Doxorubicin—lung cancer	0.00011	0.000196	CcSEcCtD
Ramipril—Hypersensitivity—Methotrexate—lung cancer	0.00011	0.000195	CcSEcCtD
Ramipril—Asthenia—Methotrexate—lung cancer	0.000107	0.00019	CcSEcCtD
Ramipril—Feeling abnormal—Doxorubicin—lung cancer	0.000106	0.000189	CcSEcCtD
Ramipril—Gastrointestinal pain—Doxorubicin—lung cancer	0.000106	0.000187	CcSEcCtD
Ramipril—Pruritus—Methotrexate—lung cancer	0.000106	0.000187	CcSEcCtD
Ramipril—Urticaria—Doxorubicin—lung cancer	0.000103	0.000182	CcSEcCtD
Ramipril—Abdominal pain—Doxorubicin—lung cancer	0.000102	0.000181	CcSEcCtD
Ramipril—Body temperature increased—Doxorubicin—lung cancer	0.000102	0.000181	CcSEcCtD
Ramipril—Diarrhoea—Methotrexate—lung cancer	0.000102	0.000181	CcSEcCtD
Ramipril—Dizziness—Methotrexate—lung cancer	9.86e-05	0.000175	CcSEcCtD
Ramipril—Hypersensitivity—Doxorubicin—lung cancer	9.52e-05	0.000169	CcSEcCtD
Ramipril—Vomiting—Methotrexate—lung cancer	9.48e-05	0.000168	CcSEcCtD
Ramipril—Rash—Methotrexate—lung cancer	9.41e-05	0.000167	CcSEcCtD
Ramipril—Dermatitis—Methotrexate—lung cancer	9.4e-05	0.000167	CcSEcCtD
Ramipril—Headache—Methotrexate—lung cancer	9.35e-05	0.000166	CcSEcCtD
Ramipril—Asthenia—Doxorubicin—lung cancer	9.27e-05	0.000164	CcSEcCtD
Ramipril—Pruritus—Doxorubicin—lung cancer	9.14e-05	0.000162	CcSEcCtD
Ramipril—Nausea—Methotrexate—lung cancer	8.86e-05	0.000157	CcSEcCtD
Ramipril—Diarrhoea—Doxorubicin—lung cancer	8.84e-05	0.000157	CcSEcCtD
Ramipril—Dizziness—Doxorubicin—lung cancer	8.54e-05	0.000151	CcSEcCtD
Ramipril—Vomiting—Doxorubicin—lung cancer	8.21e-05	0.000146	CcSEcCtD
Ramipril—Rash—Doxorubicin—lung cancer	8.14e-05	0.000144	CcSEcCtD
Ramipril—Dermatitis—Doxorubicin—lung cancer	8.14e-05	0.000144	CcSEcCtD
Ramipril—Headache—Doxorubicin—lung cancer	8.09e-05	0.000144	CcSEcCtD
Ramipril—Nausea—Doxorubicin—lung cancer	7.67e-05	0.000136	CcSEcCtD
